Glenmark Pharmaceuticals Inc., USA is voluntarily recalling 14,004 cartons of Glenmark Azelaic Acid Gel, 15 % (50 grams) due to Current Good Manufacturing Practice (CGMP) deviations. This prescription medication is used to treat skin conditions, and the recall affects specific units distributed nationwide. Consumers should consult with their healthcare provider or pharmacist regarding the use of this medication.
The recall was initiated because the product was manufactured under conditions that did not meet strict quality control standards, which may compromise the product's safety, identity, strength, or quality.
You have 2 options:
Recall #: D-0621-2024; Total quantity: 14,004 cartons
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.